RSS-Feed abonnieren
DOI: 10.1055/s-0041-1722913
The Keloid Intervention Benefit Inventory 21: A New Assessment Tool for the Quality of Life of Patients with Auricular Keloids
Abstract
The assessment of the quality of life (QoL) of patients with chronic diseases before and after medical interventions has gained increasing importance in recent decades. Particularly for patients with visible keloid scars in the head and neck region, standardized measurement tools are either absent or have been shown to be insufficient. The aim of the present study was to create a new standardized questionnaire that is specific to auricular keloid patients and reflects their clinical symptoms and QoL. The Keloid Intervention Benefit Inventory 21 (KIBI-21) questionnaire was developed in two stages. First, a group of experts identified a pool of 26 questions and modified and supplemented the items through a comparison with existing QoL assessments so that they related to keloid-specific clinical symptoms and the QoL of patients with auricular keloids before and after a medical intervention. This questionnaire was distributed to 27 outpatients who had undergone medical interventions for visible auricular keloids. Second, a sequential statistical analysis was conducted. This included a single-item assessment and reduction, analysis for internal consistency, construct validity, and divergence validity as well as a factor analysis. The analyses were performed for the entire questionnaire and for the items in the subcategories General Health, Physical Symptoms, Self-Esteem, and Social Impact. The final version of this newly validated and standardized KIBI questionnaire consisted of 21 items, of which each item was assigned to only one subscale. The questionnaire showed a Cronbach's α of 0.84 with a good internal consistency. In the item correlation validity, strong associations were found in all subscales, except for the Social Impact Subscale. The keloid-specific QoL questionnaire KIBI-21 proved to be a reliable and reproducible instrument to assess the QoL and clinical symptoms in patients suffering from auricular keloids before and after a medical treatment.
Informed Consent
Written informed consent was obtained from all the individuals.
Publikationsverlauf
Artikel online veröffentlicht:
01. Februar 2021
© 2021. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Atiyeh BS, Costagliola M, Hayek SN. Keloid or hypertrophic scar: the controversy: review of the literature. Ann Plast Surg 2005; 54 (06) 676-680
- 2 Walliczek U, Engel S, Weiss C. et al. Clinical outcome and quality of life after a multimodal therapy approach to ear keloids. JAMA Facial Plast Surg 2015; 17 (05) 333-339
- 3 Murray JC, Pollack SV, Pinnell SR. Keloids: a review. J Am Acad Dermatol 1981; 4 (04) 461-470
- 4 Murray JC. Keloids and hypertrophic scars. Clin Dermatol 1994; 12 (01) 27-37
- 5 Crockett DJ. Regional keloid susceptibility. Br J Plast Surg 1964; 17: 245-253
- 6 Monaldi archives for chest disease. Chest Dis 2019; 89 (01) ;1033: 59-61
- 7 Ring HC, Mogensen M, Hussain AA. et al. Imaging of collagen deposition disorders using optical coherence tomography. J Eur Acad Dermatol Venereol 2015; 29 (05) 890-898
- 8 Randa H, Todberg T, Skov L, Larsen LS, Zachariae R. Health-related quality of life in children and adolescents with psoriasis: a systematic review and meta-analysis. Acta Derm Venereol 2017; 97 (05) 555-563
- 9 Silverberg JI, Gelfand JM, Margolis DJ. et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol 2018; 121 (03) 340-347
- 10 Coghi S, Bortoletto MC, Sampaio SA, Andrade Junior HF, Aoki V. Quality of life is severely compromised in adult patients with atopic dermatitis in Brazil, especially due to mental components. Clinics (São Paulo) 2007; 62 (03) 235-242
- 11 Lyons AB, Peacock A, Braunberger TL, Viola KV, Ozog DM. Disease severity and quality of life outcome measurements in patients with keloids: a systematic review. Dermatol Surg 2019; 45 (12) 1477-1483
- 12 Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006; 297 (10) 433-438
- 13 Robinson K, Gatehouse S, Browning GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol 1996; 105 (06) 415-422
- 14 Schwentner I, Schmutzhard J, Deibl M, Sprinzl GM. Health-related quality of life outcome of adult patients after otoplasty. J Craniofac Surg 2006; 17 (04) 629-635
- 15 Pattisapu P, Guy WM, Brissett AE. SF-12 for head-and-neck keloid patients: preliminary results towards creating a keloid-specific scale. Otolaryngol Head Neck Surg 2013; 149: P42
- 16 Guy WM, Pattisapu P, Ongkasuwan J, Brissett AE. Creation of a head and neck keloid quality of life questionnaire. Laryngoscope 2015; 125 (12) 2672-2676
- 17 Rapp SR, Feldman SR, Exum ML, Fleischer Jr AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41 (3, Pt 1): 401-407
- 18 Furtado F, Hochman B, Ferrara SF. et al. What factors affect the quality of life of patients with keloids?. Rev Assoc Med Bras (1992) 2009; 55 (06) 700-704